Transgenic APOE−/− mice overexpressing APP show atherosclerotic lesions of increased size and with enhanced inflammation in comparison with APOE−/− mice [13], while APOE−/− mice lacking APP have less atherosclerosis than APOE−/− mice [14]. This evidence concerns the gene APP and atherosclerosis.